Close Menu

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    Truecaller Ads Launches ‘Truecaller Pulse’; An Industry First Declared Intent Media Solution

    August 6, 2026

    Immune Mediated Disease Therapeutics Developer Attovia Therapeutics Debuts on Nasdaq

    August 6, 2026

    UnionPay International and Pesapal Partner to Boost Cross-Border Payments and Tourism in East Africa

    August 6, 2026
    Facebook X (Twitter) Instagram
    Algeria News HubAlgeria News Hub
    • Automotive
    • Business
    • Entertainment
    • Health
    • Lifestyle
    • Luxury
    • News
    • Sports
    • Technology
    • Travel
    Algeria News HubAlgeria News Hub
    Home » Brewing hope – how used coffee grounds may combat Alzheimer’s and Parkinson’s
    Health

    Brewing hope – how used coffee grounds may combat Alzheimer’s and Parkinson’s

    November 22, 2023
    Facebook Twitter Pinterest LinkedIn Reddit WhatsApp Email

    In the relentless battle against neurodegenerative disorders such as Alzheimer’s, Parkinson’s, and Huntington’s, a groundbreaking discovery emerges from The University of Texas at El Paso. Researchers, exploring the unlikeliest of sources—spent coffee grounds—have unearthed a potential weapon against these debilitating conditions that afflict millions and strain healthcare budgets with hundreds of billions in annual costs.

    Brewing hope - how used coffee grounds may combat Alzheimer's and Parkinson's

    Leading the charge is Jyotish Kumar, a doctoral student in the Department of Chemistry and Biochemistry, along with Mahesh Narayan, Ph.D., a distinguished professor and Royal Society of Chemistry Fellow. Their team has identified caffeic-acid based Carbon Quantum Dots (CACQDs), derivable from used coffee grounds, as a promising agent in shielding brain cells from damage typically associated with neurodegenerative diseases, particularly those exacerbated by factors like obesity, aging, and exposure to environmental toxins.

    Their findings, detailed in the journal Environmental Research, mark a significant leap forward. “CACQDs could revolutionize neurodegenerative disease treatment,” Kumar states. Unlike existing therapies that merely manage symptoms, CACQDs aim at the root causes – the molecular triggers of these ailments. Neurodegenerative diseases, characterized by neuron loss, impair basic and complex functions—from movement and speech to cognitive abilities.

    Lifestyle and environmental factors in early stages of these diseases often lead to increased free radicals and amyloid protein fragment aggregation in the brain, contributing to the progression of these conditions. Kumar’s team discovered that CACQDs offer neuroprotection in various models of Parkinson’s disease, particularly those induced by the pesticide paraquat. The CACQDs demonstrated an ability to neutralize free radicals and prevent amyloid protein aggregation, all without notable side effects.

    This breakthrough suggests that early intervention with CACQD-based treatments could thwart the full onset of diseases like Alzheimer’s and Parkinson’s. Caffeic acid, a polyphenol known for its antioxidant properties, is uniquely capable of crossing the blood-brain barrier, thus directly impacting brain cells. The team’s “green chemistry” approach to extracting CACQDs from coffee waste—cooking grounds at 200° for four hours—is both eco-friendly and cost-effective, making this a sustainable solution.

    The project, encompassing contributions from numerous UTEP graduate and undergraduate students, including Sofia Delgado, now a Ph.D. student at Yale University, signifies a collective effort in scientific advancement. While Narayan and Kumar acknowledge the journey ahead is long, the potential of developing a simple, pill-based preventative treatment for the majority of non-genetically caused neurodegenerative disorders remains a beacon of hope.

    Share. Facebook Twitter Pinterest LinkedIn WhatsApp Reddit Email

    Related Posts

    Moderna begins Ebola vaccine trial amid DR Congo outbreak

    August 5, 2026

    Michigan reports first deaths tied to cyclospora outbreak

    August 4, 2026

    DR Congo Ebola outbreak reaches record scale

    August 3, 2026

    DR Congo Ebola outbreak reaches 2,267 cases and 893 deaths

    July 18, 2026

    Most New Ebola Cases in Congo Linked to Unknown Transmission Routes

    July 15, 2026

    DRC Ebola trial tests therapies as outbreak spreads

    July 8, 2026
    Latest News
    Business

    OECD inflation eases to 4.2% as lower energy rates take hold

    August 5, 2026

    Headline inflation across OECD economies eased to 4.2% in June 2026 from 4.6% in May, ending three straight monthly increases. The measure tracks annual changes in consumer prices across the group’s member countries. Inflation declined in 20 economies, increased in six and remained stable or broadly stable in 12. Nine OECD countries recorded inflation at or below 2%, including three where the rate stood below 1%. Energy prices drove much of the monthly easing. OECD energy inflation fell four percentage points to 11.7% year on year, after reaching 15.8% in May.

    Guatemala raises red alert as Fuego volcano erupts

    August 5, 2026

    Oil prices fall as Brent and WTI reach three-week lows again

    August 5, 2026

    Moderna begins Ebola vaccine trial amid DR Congo outbreak

    August 5, 2026

    Eastern Washington fires leave 700 structures destroyed

    August 4, 2026

    Michigan reports first deaths tied to cyclospora outbreak

    August 4, 2026

    Austria sets July heat record amid €1.4 billion losses

    August 3, 2026

    Oil prices swing after Brent tops $90 on supply strains

    August 3, 2026
    © 2026 Algeria News Hub | All Rights Reserved
    • Home
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.